arrow
O

Oreste ­Gentilini

vita salute san-raffaele university
H指数:58
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial

[18F]FDG PET/MRI在淋巴结阳性乳腺癌患者接受新辅助系统性治疗后的腋窝分期中的应用:一项前瞻性单臂试验

Breast
IF7.9
2026-07-010
PRE
Hybrid [18F]FDG PET/MR Imaging Parameters for the Prediction of Tissue Biomarkers in Invasive Ductal Breast Cancer

杂交[18F]FDG PET/MR成像参数在浸润性导管乳腺癌组织生物标志物预测中的应用

2026-04-080
OAAI
Use of prepectoral polyurethane coated implants in the setting of radiotherapy: the OPBC-09 PRExRT retrospective cohort study

在放疗背景下使用胸大肌前方聚氨酯涂层植入物的OPBC-09 PRExRT回顾性队列研究

Breast
IF7.9
2026-01-010
OA
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study

乳腺癌新辅助治疗后低体积淋巴结受累患者的腋窝清扫术:多中心AXSANA队列研究

2025-09-010
PRE
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)

新辅助化疗后乳腺癌症患者腋窝标记物丢失——来自前瞻性国际AXSANA(EUBREAST 3)队列研究(NCT04373655)的数据

2025-06-250
OA
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
2025-02-200
PRE
Radar localization for targeted axillary dissection in breast cancer patients undergoing primary systemic treatment: a sub-analysis of the AXSANA study

乳腺癌患者在接受一线系统性治疗时,利用雷达定位进行靶向腋窝清扫的亚组分析:AXSANA研究的子分析

BREAST
IF7.9
2025-02-010
OAAI
Fluorine-18 FDG PET/MRI vs Sentinel Node Biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial (NCT04829643)

氟-18 FDG PET/MRI与哨兵淋巴结活检用于早期乳腺癌患者腋窝分期的比较。一项前瞻性单臂试验(NCT04829643)

BREAST
IF7.9
2025-02-010
OAAI
CINDERELLA Clinical Trial (NCT05196269): Patient Engagement with an AI-based Healthcare Application for Enhancing Breast Cancer Locoregional Treatment Decisions- Preliminary Insights

CINDERELLA 临床试验(NCT05196269):患者参与基于AI的医疗应用程序以增强乳腺癌局部区域治疗决策的初步见解

BREAST
IF7.9
2025-02-010
OAAI
MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET, NCT 05559411)
2024-05-020
PRE
Recurrence-free survival following sentinel nodepositive breast cancer without completion axillary lymph node dissection - first results from the international randomized SENOMAC trial
2024-05-020
PRE
AXSANA - EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
2024-05-020
PRE
CINDERELLA Clinical Trial (NCT05196269): using artificial intelligence-driven healthcare to enhance breast cancer locoregional treatment decisions
2024-05-020
PRE
Magnetic seeds used for the detection of target lymph nodes after neoadjuvant therapy for early breast cancer - a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
2024-05-020
PRE
FES-PET/MRI for Tailored treatment of luminal A and lobular breast cancer: a prospective cohort study
2024-05-020
PRE
Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer - a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
2024-05-020
PRE